Reversible Corneal Endothelial Abnormalities With Netarsudil
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Ophthalmology
Reference15 articles.
1. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma;Kass;Arch Ophthalmol,2002
2. Meta-analysis of the efficacy and safety of α2-adrenergic agonists, β-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs;Tanna;Arch Ophthalmol,2010
3. Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension;Tanna;Ophthalmology,2018
4. The effects of netarsudil ophthalmic solution on aqueous humor dynamics in a randomized study in humans;Kazemi;J Ocul Pharmacol Ther,2018
5. Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: Rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2);Serle;Am J Ophthalmol,2018
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advantages and disadvantages of using Rho kinase inhibitors to reduce intraocular pressure;Expert Review of Ophthalmology;2024-02-12
2. The Multifarious Effects of Various Glaucoma Pharmacotherapy on Corneal Endothelium: A Narrative Review;Ophthalmology and Therapy;2023-03-17
3. Rho-kinase inhibitors: Role in corneal endothelial disorders;Seminars in Ophthalmology;2022-08-21
4. Reticular epithelial edema after penetrating keratoplasty in a patient taking netarsudil;Digital Journal of Ophthalmology;2022-06-27
5. “Rapid and reversible alteration in corneal contour and power associated with Netarsudil/Latanoprost”;American Journal of Ophthalmology Case Reports;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3